ESMO - European Society for Medical Oncology

ESMO - European Society for Medical Oncology The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.

Representing more than 40,000 oncology professionals from 177 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of , offering , and advocating for .

📣   : How can AI transform cancer research and patient care responsibly? We invite researchers, clinicians, data scienti...
22/06/2026

📣 : How can AI transform cancer research and patient care responsibly?

We invite researchers, clinicians, data scientists, digital health specialists, and industry innovators to submit their abstracts and contribute to critical discussions on:
✓ AI innovation in oncology
✓ Human-AI interaction
✓ Ethical and regulatory considerations
✓ Real-world deployment
✓ Agentic and autonomous AI systems

Share your findings and help advance the future of oncology.
⏰ Submit your abstract by 1 September 2026.

🔗 https://ow.ly/kS4E50ZehxT

How do you translate   guidelines into real-world practice?🔗 https://ow.ly/X7ZF50Zev15Join the upcoming ESMO Guidelines ...
22/06/2026

How do you translate guidelines into real-world practice?

🔗 https://ow.ly/X7ZF50Zev15

Join the upcoming ESMO Guidelines Webinar and gain expert insights on:
✔ Immunotherapy & targeted treatments
✔ Patient selection and sequencing
✔ Real-world case discussions

🎓 1 ESMO-MORA point | Free registration

🙌 And that's a wrap at ESMO Gynaecology 2026 in Copenhagen!A heartfelt thank you to every speaker who stopped by the ESM...
19/06/2026

🙌 And that's a wrap at ESMO Gynaecology 2026 in Copenhagen!

A heartfelt thank you to every speaker who stopped by the ESMO Live Recording booth to share their research. We had a fantastic few days and cannot wait to bring you the final interviews very soon.

👏 Congratulations to the   recipients at  . As part of ESMO’s commitment to supporting the next generation within the  ,...
17/06/2026

👏 Congratulations to the recipients at .
As part of ESMO’s commitment to supporting the next generation within the , we are proud to recognise these young researchers for the scientific merit of their abstracts.
🔗 https://ow.ly/TqMP50Zc9i2

17/06/2026

🙌 : Welcome to the global meeting place for gynaecological cancer specialists. Discover the latest science, share real-world experience, and collaborate with international experts to shape the future of patient care.

Get ready to participate in sessions covering:
➡️ Practice-changing progress in the treatment of patients with gynaecological cancers
➡️ Recent developments in therapies integrating PARP inhibitors, targeted agents and ADCs for managing patients with ovarian cancer
➡️ State-of-the-art in diagnosis and management of cervical and endometrial cancers
➡️ Bench to bedside research perspectives in gynaecological oncology
➡️ Novel therapeutic strategies for rare gynaecological cancers

🔗 https://ow.ly/EVt050Zcfjt

👉 In this  , we turn the complexity of metastatic hormone‑sensitive   into practical strategies for everyday care—optimi...
16/06/2026

👉 In this , we turn the complexity of metastatic hormone‑sensitive into practical strategies for everyday care—optimising treatment, navigating sequencing decisions, and translating key evidence into real‑world practice. Plus a live Q&A 💬

🔗 ESMO member: register now to secure your seat - https://ow.ly/qFBG50ZbJ8z

What will you learn?
- A deeper understanding of the clinical course of genitourinary cancers
- How classification and risk stratification are evolving, and what this means for research and treatment development
- Strengthen skills for critical analysis and interpretation of research data and therapeutic strategies
- Build confidence for informed, innovative thinking and engagement in ongoing or new research projects

🗓️ Date & time: 17 June at 18:30 CEST
🎙️ Chair & speakers: Silke Gillessen, Elena Castro, Karim Fizazi, Hoda Abdel-Aty
🎓 CME: Live viewers earn 2 ESMO‑MORA Category 1 points.

📣 On-demand resources from   are now available on OncologyPRO, supporting ongoing collaboration in early-phase oncology ...
15/06/2026

📣 On-demand resources from are now available on OncologyPRO, supporting ongoing collaboration in early-phase oncology research across Asia-Pacific and beyond.

🔗 https://ow.ly/Z3Km50ZaYFS

Explore the latest insights in and targeted anticancer therapies, directly from leading experts in the field.
📌 Access is available for sessions where speaker permission has been granted.

15/06/2026

👉 It’s not too late to join in Munich (1–4 July)!

Explore the latest in GI oncology: immunotherapy breakthroughs, precision medicine, ctDNA & biomarkers, AI-driven innovation, and multidisciplinary care across CRC, pancreatic, HCC & more. Register now!

🔗 https://ow.ly/iw3F50ZaYwr

📣 Abstract submission is now open for the ESMO Immuno-Oncology & Advanced Therapies Congress 2026.Share your research wi...
15/06/2026

📣 Abstract submission is now open for the ESMO Immuno-Oncology & Advanced Therapies Congress 2026.

Share your research with a global community working to advance cancer treatment across immuno-oncology and advanced therapies.

From cancer immunology and translational research to cell therapies, vaccines, immune engineering, biomarkers and emerging therapeutic strategies, the congress will bring together experts across the field to exchange insights and explore what’s next.

🔗 https://ow.ly/eSC350ZaYAw

📍 Onsite in London, United Kingdom, and online
📅 14–16 December 2026
🗓️ Abstract submission deadline: 22 September 2026, 21:00 CEST

Already planning to join us? Registration is open.

Submit your abstract and be part of the conversation.

👏 Congratulations to the   recipients at  . As part of ESMO’s commitment to supporting the next generation within the  ,...
12/06/2026

👏 Congratulations to the recipients at .
As part of ESMO’s commitment to supporting the next generation within the , we are proud to recognise these young researchers for the scientific merit of their abstracts.

🔗 https://ow.ly/Y6Bm50Z8EQM

Adresse

ESMO Headquarters, Via Ginevra, 4
Lugano
6900

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 18:00
Mittwoch 09:00 - 18:00
Donnerstag 09:00 - 18:00
Freitag 09:00 - 18:00

Telefon

+41919731900

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von ESMO - European Society for Medical Oncology erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Organisation Kontaktieren

Nachricht an ESMO - European Society for Medical Oncology senden:

Teilen